Crossmark

The Role of Clinical Trials in Preclinical Alzheimer's Disease Drug Development Programs

Crossref DOI link: https://doi.org/10.14283/jpad.2020.28

Published Print: 2020-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cummings, Jeffrey
License Information

Text and Data Mining valid from 2020-09-01

Text and Data Mining valid from 2020-09-01

Version of Record valid from 2020-05-06
More Information

This article is maintained by: Elsevier

Article Title: The Role of Clinical Trials in Preclinical Alzheimer's Disease Drug Development Programs

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2020.28

Content Type: article

Copyright: Copyright © 2020 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS